Genor Biopharma
IPOPublic · Shanghai, China · $160.0M raised
- Headquarters
- Shanghai
- Employees
- 201–500
- Business Model
- B2B
- Website
- genorbio.com
- Total Funding
- $160.0M
- Last Round
- $160.0M Series BJun 2020
- Rounds
- 1
- Type
- Public
About
Innovation-driven biopharmaceutical company developing and commercializing oncology and autoimmune drugs, headquartered in Shanghai.
Summary
Genor Biopharma is a Biotech company based in Shanghai, China. It has raised $160.0M in total across 1 round, most recently a $160.0M Series B round in Jun 2020. Investors include Hillhouse Capital, Temasek and CR-CP Life Science Fund.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
BridgeBio makes targeted treatments for genetic diseases.
Novel bicyclic peptides and drug conjugates for cancer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform